A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2004
12/08/2004	EP1127052B1 Substituted 2-phenylbenzimidazoles, the production thereof and their use
12/08/2004	EP1121354B1 N-(imidazolylalkyl)substituted cyclic amines as histamine-h 3 agonists or antagonists
12/08/2004	EP0812190B1 R-enantiomer of n-propargyl-1-aminoindan for the treatment of various diseases and mesylate, esylate and sulfate thereof
12/08/2004	CN1553905A Novel urea compounds as vanilloid receptor antagonist for treatment of pains
12/08/2004	CN1553814A Remedies for arteriosclerosis
12/08/2004	CN1553813A Complement pathway inhibitors binding to C5 and C5A without preventing formation of C5B
12/08/2004	CN1553811A Human tissue urokinase type plasminogen activator formulation
12/08/2004	CN1553806A Use of SAPR-1 for the treatment and/or prevention of scleroderma
12/08/2004	CN1553800A Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders
12/08/2004	CN1553798A Modifying the fatty acid composition of cell membranes of organs and tissues
12/08/2004	CN1552855A Vascular endothelial growth factor 2
12/08/2004	CN1552733A Preparation of myocardium peptide
12/08/2004	CN1552723A Liaodong oak leaf saponin and its medicinal composition
12/08/2004	CN1552720A N,O-carboxymethyl chitoligose preparation and use
12/08/2004	CN1552450A Ligustrazine cyclodextrin dressing material, its preparation and preparing method
12/08/2004	CN1552449A Baicalin cyclodextrin clathrate compound, preparation and preparing method thereof
12/08/2004	CN1552431A Chinese medicinal preparation for lowering viscosity and preventing embolism
12/08/2004	CN1552416A Medicine composition application for preparing hypertension medicine
12/08/2004	CN1552413A Internal medicine for treating SARS, AIDS virus, preparing method and use thereof
12/08/2004	CN1552403A Pressure rising capsule
12/08/2004	CN1552400A Anagetic muscle regenerating paste for pile
12/08/2004	CN1552384A Yilingjing pills and their preparation
12/08/2004	CN1552379A Double red blood circulating pills and their preparation
12/08/2004	CN1552348A Sedinafine composition and its use
12/08/2004	CN1552343A Sodium alginate diester drops and their preparing method
12/08/2004	CN1552338A Medicine for preventing cardiovascular disease
12/08/2004	CN1552337A Medicine for preventing cerebrovascular disease
12/08/2004	CN1552335A Ginseng and ophiopogon saponin drops and their preparing method
12/08/2004	CN1552334A Medicinal composition for treating cardiovascular disease
12/08/2004	CN1552323A Monolayer osmotic pump controlled releasing tablets of nimodipine
12/08/2004	CN1552319A Bilobanone drops
12/08/2004	CN1552318A Hawthorn leave flavone capsules and their preparing method
12/08/2004	CN1552317A Preparation of Xindakang
12/08/2004	CN1552315A 治疗组合物 The therapeutic composition
12/08/2004	CN1552309A Method for promoting solid cilostazol to dissolve out
12/08/2004	CN1178941C CRF receptor antagonists and method relating thereof
12/08/2004	CN1178940C Selective antagonists of A28 adenosine receptors
12/08/2004	CN1178936C Sulfonyl-pyrrolidine derivatives
12/08/2004	CN1178932C Amide derivatives
12/08/2004	CN1178923C 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists
12/08/2004	CN1178922C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
12/08/2004	CN1178921C Preparation of sulfonamides
12/08/2004	CN1178917C N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
12/08/2004	CN1178696C Preparation for treatment of metabolic syndrome containing human growth hormone in combination with cortisol synthesis inhibitor
12/08/2004	CN1178683C Cerebral hemorrhage treating traditional Chinese medicine
12/08/2004	CN1178682C Angiocardiopathy treating traditional Chinese medicine
12/08/2004	CN1178669C Injection for treating pile and fistula and its preparing process
12/08/2004	CN1178656C Pharmaceutical composition
12/07/2004	US6828462 Amines such as 3,3,5,5-Tetramethyl-1-vinylcyclohexanamine hydrochloride, used as N-methyl-D-aspartate (NMDA), serotonin and nicotinic acetylcholine receptor antagonists
12/07/2004	US6828456 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
12/07/2004	US6828447 Therapeutic agent for use in the treatment of cardiovascular and inflammatory disorders
12/07/2004	US6828446 Aromatic thioether liver X-receptor modulators
12/07/2004	US6828440 Analgesics; side effect reduction
12/07/2004	US6828418 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
12/07/2004	US6828351 Methods and compositions for regulating memory consolidation
12/07/2004	US6828350 Inhibiting the activity of a picornavirus 3C protease or a cysteine protease with a composition having an orthohydroxy keto aryl core structure
12/07/2004	US6828343 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors
12/07/2004	US6828339 Amlodipine salt forms and processes for preparing them
12/07/2004	US6828338 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
12/07/2004	US6828335 Oxazole or thiazole-ethyl-oxy-indane acetic acid derivatives; useful for the treatment of diseases such as diabetes, obesity, hyperlipidemia and atherosclerosis
12/07/2004	US6828332 Piperidine derivatives as reuptake inhibitors
12/07/2004	US6828327 Macroheterocylic compounds useful as kinase inhibitors
12/07/2004	US6828324 Branched adamantyl and noradamantyl aryl-and aralkylpiperazines with serotonin 5-HT1A activity
12/07/2004	US6828319 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
12/07/2004	US6828318 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
12/07/2004	US6828315 1-Amino triazoloc4,3-a! quinazoline-5-ones and/or -5-thiones inhibiting phosphodiesterase IV
12/07/2004	US6828312 Therapy of mammal susceptible to, suffering from, suspected of having or recovering from a disease impacted by tissue factor(TF), by administering TF blocking compound
12/07/2004	US6828306 Charged lipid compositions and methods for their use
12/07/2004	US6827926 Administering a porphyrin compound that coordinates gallium in the central pyrrolic core, and irradiating porphyrin compound with energy at a wavelength capable of exciting the molecule to achieve the desired detection or therapeutic effect
12/07/2004	CA2316921C Aryl fused azapolycyclic compounds
12/07/2004	CA2208673C Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin
12/07/2004	CA2150123C Aminomethylene substituted non-aromatic heterocycles
12/07/2004	CA2108817C Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, medicaments containing these compounds and their use, and processes for their preparation
12/02/2004	WO2004104182A1 Bioactive peptide-producing strains of enterococcus faecalis, bioactive peptides and applications thereof
12/02/2004	WO2004104027A1 Composition containing angiotensin converting enzyme inhibitory peptide
12/02/2004	WO2004104009A1 Process for making spirolactone compounds
12/02/2004	WO2004104003A1 Novel pyridopyrazines and use thereof as kinase modulators
12/02/2004	WO2004104001A2 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase
12/02/2004	WO2004103997A1 TETRAHYDROISOQUINOLINE DERIVATIVES AS PPAR-α ACTIVATORS
12/02/2004	WO2004103992A1 2-aminoquinoline derivative
12/02/2004	WO2004103946A1 Carboxylic acid compound and medicine containing the same
12/02/2004	WO2004103407A2 Composition comprising a pde4 inhibitor and a pde5 inhibitor
12/02/2004	WO2004103403A1 Immunocompetent cell activation inhibitor and use thereof
12/02/2004	WO2004103385A1 A medicament for treatment of hypertension
12/02/2004	WO2004103352A1 Ras antagonists for treating neurodegenerative disorders
12/02/2004	WO2004103286A2 Compositions of a cyclooxygenase-2 selective inhibitor and a cholimergic agent
12/02/2004	WO2004082454A3 Endovascular implant with an at least sectional active coating made of radjadone and/or a ratjadone derivative
12/02/2004	WO2004026815A3 Phenol derivatives and their use as rotamase inhibitors
12/02/2004	WO2003095667A3 Autoimmune conditions and nadph oxidase defects
12/02/2004	WO2003085377A3 Novel pancortin-pablo protein interactions and methods of use thereof
12/02/2004	WO2003078465A8 The use of an epitope of vascular endothelial growth factor receptor kdr/flk-1
12/02/2004	WO2003039452A3 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
12/02/2004	WO2003011106A3 Internal image antibodies for optical imaging and therapy
12/02/2004	US20040243226 Means and method for the treatment of coronary artery obstructions
12/02/2004	US20040243097 Antiproliferative drug and delivery device
12/02/2004	US20040242928 Reverse hydroxamic acid derivatives
12/02/2004	US20040242890 Agonists of beta-adrenoceptors
12/02/2004	US20040242884 3-Substituted-7-oxo-4,7-dihydro-thieno(3,2-b)pyridine-6-carboxylic acid benzylamide derivatives; for herpes viruses
12/02/2004	US20040242871 Nitric oxide synthease inhibitors; antiinflamamtory agents; analgesics; inflamamtory bowel disorders; antiarthritic agents;
12/02/2004	US20040242868 Controlling cytokines; antiinflammatory agents; rheumatic disoreders; skin disorders; respiratory system disorders; Alzheimer's disease; Parkinson's disease; Huntington"s disease ; amyotrophic lateral sclerosis

1 ... 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 ... 1595